Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multi-omics proposes a complement-adhesion-stromal-vascular (CASVR) framework in chronic rhinosinusitis with nasal polyps

View ORCID ProfileZi-Ang Ma, View ORCID ProfileXiang Gao, JinLiang Yu, Yu Song, Junxiu Liu
doi: https://doi.org/10.64898/2026.10.13.26365478
Zi-Ang Ma
1Peking University First Hospital, Beijing, China
2Peking University Health Science Center, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zi-Ang Ma
Xiang Gao
1Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xiang Gao
JinLiang Yu
3School of Information Science and Technology, Peking University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Song
1Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: songyu-{at}bjmu.edu.cn liujunxiusanyuan{at}sina.com
Junxiu Liu
1Peking University First Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: songyu-{at}bjmu.edu.cn liujunxiusanyuan{at}sina.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Type 2 inflammation is central to chronic rhinosinusitis with nasal polyps (CRSwNP), but it does not fully explain persistent stromal and vascular remodeling. We asked whether complement, adhesion, stromal, and vascular signals converge across tissue, cellular, and spatial scales. We integrated four bulk-transcriptomic cohorts with a single-cell atlas and GeoMx spatial transcriptomics. Network analysis identified eight contrast-associated hub genes and an ABCC9-ACTA2-GPM6A score that separated study-defined groups across cohorts. Single-cell mapping localized these genes mainly to pericytes, fibroblasts, and endothelial cells, while CellChat linked structural and immune compartments through extracellular-matrix and inflammatory signals. In spatial data, C3-C3AR1 showed closer-than-random proximity after multiple-testing correction, whereas ICAM1-ITGAL/ITGB2 did not. Anatomical-site sensitivity analyses retained all eight hub-gene directions. These findings support CASVR as an association framework linking complement-related signals to structural-vascular compartments and identify C3-C3AR1 for independent mechanistic testing.

Competing Interest Statement

The authors have declared no competing interest.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The datasets analysed in this study are publicly available in the Gene Expression Omnibus under accession numbers GSE136825, GSE23552, GSE194282, GSE179265, and GSE276503, and in Zenodo at https://doi.org/10.5281/zenodo.13947018. Data needed to evaluate the conclusions are available from these repositories and the accompanying Supplementary Information. Record-level gene-compound associations, displayed network edges, and redocking settings and results are supplied as Supplementary Data 1-3.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The datasets analysed in this study are publicly available in the Gene Expression Omnibus under accession numbers GSE136825, GSE23552, GSE194282, GSE179265, and GSE276503, and in Zenodo at https://doi.org/10.5281/zenodo.13947018. Data needed to evaluate the conclusions are available from these repositories and the accompanying Supplementary Information. Record-level gene-compound associations, displayed network edges, and redocking settings and results are supplied as Supplementary Data 1-3.

https://doi.org/10.5281/zenodo.13947018

https://www.omicsdi.org/dataset/geo/GSE179265

https://www.omicsdi.org/dataset/geo/GSE194282

https://www.omicsdi.org/dataset/geo/GSE276503

https://www.omicsdi.org/dataset/geo/GSE23552

Funder Information Declared

Peking University-Golden Resource Tengyun Clinical Research Program, TY2025010
Peking University First Hospital Science and Technology Achievement Transformation Incubation Guidance Fund Project, 2025CX12
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 14, 2026.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Multi-omics proposes a complement-adhesion-stromal-vascular (CASVR) framework in chronic rhinosinusitis with nasal polyps
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multi-omics proposes a complement-adhesion-stromal-vascular (CASVR) framework in chronic rhinosinusitis with nasal polyps
Zi-Ang Ma, Xiang Gao, JinLiang Yu, Yu Song, Junxiu Liu
medRxiv 2026.10.13.26365478; doi: https://doi.org/10.64898/2026.10.13.26365478
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Multi-omics proposes a complement-adhesion-stromal-vascular (CASVR) framework in chronic rhinosinusitis with nasal polyps
Zi-Ang Ma, Xiang Gao, JinLiang Yu, Yu Song, Junxiu Liu
medRxiv 2026.10.13.26365478; doi: https://doi.org/10.64898/2026.10.13.26365478

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Otolaryngology
Subject Areas
All Articles
  • Addiction Medicine (638)
  • Allergy and Immunology (922)
  • Anesthesia (353)
  • Cardiovascular Medicine (5024)
  • Dentistry and Oral Medicine (496)
  • Dermatology (429)
  • Emergency Medicine (680)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1696)
  • Epidemiology (16286)
  • Forensic Medicine (36)
  • Gastroenterology (1243)
  • Genetic and Genomic Medicine (7298)
  • Geriatric Medicine (754)
  • Health Economics (1095)
  • Health Informatics (5307)
  • Health Policy (1476)
  • Health Systems and Quality Improvement (1837)
  • Hematology (599)
  • HIV/AIDS (1383)
  • Infectious Diseases (except HIV/AIDS) (16508)
  • Intensive Care and Critical Care Medicine (1203)
  • Medical Education (701)
  • Medical Ethics (157)
  • Nephrology (754)
  • Neurology (7621)
  • Nursing (380)
  • Nutrition (1133)
  • Obstetrics and Gynecology (1297)
  • Occupational and Environmental Health (1041)
  • Oncology (3752)
  • Ophthalmology (1097)
  • Orthopedics (411)
  • Otolaryngology (468)
  • Pain Medicine (503)
  • Palliative Medicine (143)
  • Pathology (722)
  • Pediatrics (1864)
  • Pharmacology and Therapeutics (758)
  • Primary Care Research (788)
  • Psychiatry and Clinical Psychology (6156)
  • Public and Global Health (10017)
  • Radiology and Imaging (2543)
  • Rehabilitation Medicine and Physical Therapy (1527)
  • Respiratory Medicine (1274)
  • Rheumatology (663)
  • Sexual and Reproductive Health (806)
  • Sports Medicine (599)
  • Surgery (806)
  • Toxicology (109)
  • Transplantation (320)
  • Urology (309)